Profile data is unavailable for this security.
About the company
KISSEI PHARMACEUTICAL CO.,LTD. is a Japan-based company mainly engaged in the manufacture and sale of pharmaceutical products. The Company is engaged in the collection and analysis of medicine development information, and the manufacture and sale of medicines. It is also engaged in the purchase and sale of related materials, system development and information process work, construction contract work such as new construction, expansion and renovation of factories, laboratories and offices, the management of facility and equipment work, information collection and development support work, noodle manufacture and sale, and insurance agency business.
- Revenue in JPY (TTM)88.33bn
- Net income in JPY11.96bn
- Incorporated1946
- Employees1.78k
- LocationKissei Pharmaceutical Co Ltd19-48, YoshinoMATSUMOTO-SHI 399-8710JapanJPN
- Phone+81 263259081
- Fax+81 263257899
- Websitehttps://www.kissei.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mochida Pharmaceutical Co Ltd | 105.16bn | 5.69bn | 109.53bn | 1.51k | 18.77 | 0.8165 | 12.70 | 1.04 | 160.36 | 160.36 | 2,966.32 | 3,686.67 | 0.6595 | 1.62 | 3.16 | 69,734,090.00 | 3.57 | 4.50 | 4.24 | 5.44 | 51.15 | 52.49 | 5.41 | 6.87 | 3.47 | 40.43 | 0.0026 | 43.01 | 2.21 | 0.6516 | 25.03 | 4.34 | 1.98 | 0.00 |
| Zeria Pharmaceutical Co Ltd | 87.31bn | 9.94bn | 110.70bn | 1.75k | 9.25 | 1.03 | 6.32 | 1.27 | 225.42 | 225.42 | 1,980.76 | 2,031.33 | 0.5638 | 1.51 | 3.70 | 50,006,380.00 | 6.44 | 4.67 | 9.95 | 7.47 | 73.25 | 72.17 | 11.42 | 9.02 | 0.9752 | -- | 0.3209 | 28.75 | 15.30 | 7.64 | 28.52 | 27.71 | 16.51 | 6.69 |
| Towa Pharmaceutical Co Ltd | 259.59bn | 18.99bn | 164.85bn | 4.79k | 8.30 | 0.9179 | 4.22 | 0.635 | 385.70 | 385.70 | 5,273.63 | 3,486.39 | 0.5759 | 1.57 | 3.69 | 54,217,630.00 | 4.21 | 3.89 | 5.18 | 5.07 | 36.49 | 37.81 | 7.31 | 6.61 | 1.58 | -- | 0.5737 | 21.52 | 13.89 | 18.65 | 17.39 | 5.53 | 46.23 | 9.73 |
| Kaken Pharmaceutical Co Ltd | 94.04bn | 13.95bn | 169.89bn | 1.13k | 10.34 | 0.9684 | 10.30 | 1.81 | 372.31 | 372.31 | 2,464.10 | 3,974.44 | 0.5195 | 1.96 | 4.23 | 83,512,430.00 | 7.70 | 5.99 | 8.92 | 6.87 | 62.25 | 56.17 | 14.83 | 12.91 | 3.04 | -- | 0.0246 | 59.58 | 30.52 | 1.05 | 73.77 | -6.36 | 14.81 | 0.00 |
| Torii Pharmaceutical Co Ltd | 61.66bn | 5.56bn | 182.02bn | 592.00 | 31.98 | 1.47 | 30.56 | 2.95 | 197.61 | 197.61 | 2,193.40 | 4,311.56 | 0.4573 | 2.46 | 2.25 | 104,152,000.00 | 4.12 | 3.01 | 4.59 | 3.36 | 44.39 | 47.87 | 9.01 | 7.91 | 5.15 | -- | 0.00 | 61.32 | 10.59 | 7.04 | 22.41 | -28.70 | -19.90 | 20.11 |
| Kissei Pharmaceutical Co Ltd | 88.33bn | 11.96bn | 198.04bn | 1.78k | 15.49 | 0.8715 | 11.94 | 2.24 | 274.64 | 274.64 | 2,024.90 | 4,882.69 | 0.3498 | 1.73 | 3.04 | 49,679,420.00 | 4.74 | 4.26 | 5.11 | 4.60 | 49.89 | 48.59 | 13.56 | 14.30 | 4.95 | -- | 0.0075 | 32.41 | 16.87 | 6.91 | 7.18 | 33.54 | 31.04 | 13.97 |
| Nippon Shinyaku Co Ltd | 160.23bn | 32.56bn | 219.75bn | 2.24k | 6.47 | 0.8532 | 5.70 | 1.37 | 483.40 | 483.40 | 2,379.02 | 3,666.27 | 0.5858 | 1.25 | 3.63 | 71,436,470.00 | 11.90 | 10.89 | 13.60 | 12.74 | 68.10 | 63.93 | 20.32 | 17.67 | 3.54 | -- | 0.0109 | 30.58 | 8.08 | 6.56 | 25.94 | 14.06 | 80.48 | 7.59 |
| Sawai Group Holdings Co Ltd | 189.02bn | 2.17bn | 227.13bn | 3.31k | 211.15 | 1.31 | 13.04 | 1.20 | 9.32 | 82.53 | 1,518.81 | 1,505.86 | 0.5132 | 1.26 | 3.56 | 57,106,950.00 | 0.590 | -0.2327 | 0.8126 | -0.3187 | 29.81 | 32.95 | 1.15 | -0.475 | 0.8847 | 4.56 | 0.3536 | 191.65 | 6.88 | 0.7009 | -87.38 | -35.38 | 8.65 | 4.11 |
| Tsumura & Co | 181.09bn | 32.43bn | 278.48bn | 4.27k | 8.49 | 0.9143 | 6.09 | 1.54 | 427.12 | 427.12 | 2,385.35 | 3,968.06 | 0.4058 | 0.72 | 2.73 | 42,390,680.00 | 7.74 | 5.53 | 9.75 | 6.85 | 50.02 | 49.39 | 19.06 | 14.50 | 2.62 | -- | 0.1766 | 31.65 | 20.05 | 8.00 | 94.10 | 18.69 | 23.07 | 16.27 |
Data as of Jul 18 2025. Currency figures normalised to Kissei Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
16.48%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Brandes Investment Partners LPas of 15 May 2024 | 2.54m | 5.30% |
| The Vanguard Group, Inc.as of 02 Jul 2025 | 1.33m | 2.79% |
| Nomura Asset Management Co., Ltd.as of 03 Jul 2025 | 999.70k | 2.09% |
| JPMorgan Asset Management (Japan) Ltd.as of 30 Apr 2025 | 627.40k | 1.31% |
| Nikko Asset Management Co., Ltd.as of 04 Jul 2025 | 468.60k | 0.98% |
| Daiwa Asset Management Co. Ltd.as of 30 May 2025 | 449.60k | 0.94% |
| Wellington Management Co. LLPas of 31 May 2025 | 418.04k | 0.87% |
| BlackRock Fund Advisorsas of 03 Jul 2025 | 403.50k | 0.84% |
| Dimensional Fund Advisors LPas of 30 May 2025 | 382.80k | 0.80% |
| Amundi Japan Ltd.as of 10 Jul 2025 | 270.20k | 0.56% |
More ▼
Data from 31 Mar 2025 - 31 Mar 2025Source: FactSet Research Systems Inc.
